Scott Kozak

Head, Licensing, Corporate & Business Development

Mr. Kozak brings more than 30 years of experience in the pharmaceutical industry in sales, marketing, brand management, business development, licensing & corporate development; having worked in such companies as Forest Labs, Hoffmann La Roche and Solvay Pharmaceuticals. Scott has also worked for start-up pharmaceutical companies EpiCept and RHEI Pharmaceuticals, helping those companies to partner, raise funds and, in the case of EpiCept, go public. Over the past decade, focusing on entrepreneurial endeavors, Mr. Kozak co-founded several companies; New Haven Pharmaceuticals, Prevention Pharmaceuticals and Rho Renewables. Through his consulting company, Bennett Biotech, he is working with several young companies including Universal Sequencing Technology (UST), a next-generation DNA Sequencing company located in the Boston area, and Potentiometric Probes, a company born out of UConn that is marketing Voltage-Sensitive Dyes for cardiovascular & neurological drug discovery. Mr. Kozak is an Adjunct Faculty member at the University of Connecticut School of Business and an instructor and mentor at UConn’s Connecticut Center for Entrepreneurship and Innovation (CCEI).